tranylcypromine has been researched along with Endometriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Guo, SW; Liu, X | 1 |
| Ding, D; Guo, SW; Liu, X; Sun, Q | 1 |
2 other study(ies) available for tranylcypromine and Endometriosis
| Article | Year |
|---|---|
Overexpression of lysine-specific demethylase 1 in ovarian endometriomas and its inhibition reduces cellular proliferation, cell cycle progression, and invasiveness.
Topics: Adult; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Choristoma; Dose-Response Relationship, Drug; Endometriosis; Female; Gene Expression Regulation, Neoplastic; Histone Demethylases; Humans; Middle Aged; Neoplasm Invasiveness; Tranylcypromine; Young Adult | 2014 |
Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis.
Topics: Animals; Biomarkers; Cell Proliferation; Endometriosis; Female; Histone Code; Histone Demethylases; Histones; Hyperalgesia; Immunohistochemistry; Methylation; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Neovascularization, Pathologic; Tranylcypromine | 2016 |